🇺🇸 FUZEON [enfuvirtide] in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Accidental Needle Stick — 2 reports (33.33%)
- Device Failure — 1 report (16.67%)
- Impaired Work Ability — 1 report (16.67%)
- Injection Site Discolouration — 1 report (16.67%)
- Injection Site Reaction — 1 report (16.67%)
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is FUZEON [enfuvirtide] approved in United States?
FUZEON [enfuvirtide] does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for FUZEON [enfuvirtide] in United States?
Hoffmann-La Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.